大和:升药明康德(02359)目标价至138港元 第三季业绩胜预期
智通财经网·2025-10-28 07:25

Core Viewpoint - Daiwa's report indicates that WuXi AppTec (02359) experienced a 15% year-on-year increase in revenue for Q3, reaching 12.1 billion RMB, and a 53% increase in net profit to 3.5 billion RMB, surpassing market expectations by 5% and 15% respectively [1] Financial Performance - Q3 revenue increased by 15% year-on-year to 12.1 billion RMB [1] - Net profit rose by 53% year-on-year to 3.5 billion RMB [1] - Chemical business revenue grew by 23% year-on-year [1] - Gross margin improved by 7.8 percentage points year-on-year [1] Guidance and Ratings - The company raised its full-year revenue guidance for continuing operations from a growth of 13-17% to 17-18% [1] - The total revenue target for the year was adjusted from 42.5-43.5 billion RMB to 43.5-44 billion RMB [1] - Daiwa maintains a "Buy" rating and has increased the target price from 134 HKD to 138 HKD based on the revised gross margin forecast [1]